Shared on behalf of Chad Johnson, Acting VP Patient Experience, Chief Nursing Executive, Regional VP Regional Cancer Centre and Jennifer Wintermans, VP, Quality and Corporate Affairs
In follow-up to the memo circulated on September 15, 2023, please note that all Baxter Novum IQ Large Volume Pumps have now been inspected and preventive maintenance performed. For this reason, we are discontinuing the use of Buretrols when administrating high risk medication on the Baxter Novum IQ Large Volume Pump as a precautionary measure.
In addition, you will no longer be required to inspect the pumping mechanism valves prior to infusion as the preventative maintenance has resolved this issue.
Please note that all IV pumps that have completed preventative maintenance are identified with a bright pink sticker. If you locate an IV pump that does not have a bright pink sticker, please bring it to your Manager who will follow-up with the Biomedical Department.
Thank you everyone for your extra efforts and cooperation as the Leadership Team and the Baxter Team worked to resolve this issue. If you should have any questions about this memo or this situation, we ask that you please address them to your Manager.